Argus downgraded Hologic (HOLX) to Hold from Buy as the company had agreed in October to be acquired by funds managed by Blackstone (BX) and TPG (TPG) in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3B. The transaction is expected to close in early February, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Hologic downgraded to Hold from Buy at Argus
- Evercore ISI upgrades four, downgrades six in MedTech and Tools
- Hologic downgraded to In Line from Outperform at Evercore ISI
- Hologic downgraded to Neutral from Outperform at BNP Paribas Exane
- Hologic’s Financial Health at Risk: Navigating Reimbursement and Guideline Challenges